Cargando…

Role of BCLAF‐1 in PD‐L1 stabilization in response to ionizing irradiation

Programmed cell death ligand 1 (PD‐L1) is a major immunosuppressive checkpoint protein expressed by tumor cells to subvert anticancer immunity. Recent studies have shown that ionizing radiation (IR) upregulates the expression of PD‐L1 in tumor cells. However, whether an IR‐induced DNA damage respons...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ma, Zhao, Wang, Han, Meng, Fanbiao, Han, Yamei, Chen, Yefei, Xiao, Mingming, Jiang, Hongjing, Yu, Zhentao, Xu, Bo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8486183/ https://www.ncbi.nlm.nih.gov/pubmed/34251713 http://dx.doi.org/10.1111/cas.15056

Ejemplares similares

Rho‐associated protein kinase‐dependent moesin phosphorylation is required for PD‐L1 stabilization in breast cancer
por: Meng, Fanbiao, et al.
Publicado: (2020)

In Search of a Function for BCLAF1
por: Sarras, Haya, et al.
Publicado: (2010)

Function of BCLAF1 in human disease
por: Yu, Zongdong, et al.
Publicado: (2022)

BCLAF1 induces cisplatin resistance in lung cancer cells
por: Jiang, Tao, et al.
Publicado: (2020)

Bclaf1 critically regulates the type I interferon response and is degraded by alphaherpesvirus US3
por: Qin, Chao, et al.
Publicado: (2019)

Bclaf1 promotes angiogenesis by regulating HIF-1α transcription in hepatocellular carcinoma
por: Wen, Ying, et al.
Publicado: (2018)

miR-194-5p/BCLAF1 deregulation in AML tumorigenesis
por: Dell'Aversana, C, et al.
Publicado: (2017)

Erratum: miR-194-5p/BCLAF1 deregulation in AML tumorigenesis
por: Dell'Aversana, C, et al.
Publicado: (2017)

A Tumor-Immune Interaction Model for Synergistic Combinations of Anti PD-L1 and Ionizing Irradiation Treatment
por: Byun, Jong Hyuk, et al.
Publicado: (2020)

Cry2 Is Critical for Circadian Regulation of Myogenic Differentiation by Bclaf1-Mediated mRNA Stabilization of Cyclin D1 and Tmem176b
por: Lowe, Matthew, et al.
Publicado: (2018)

The long noncoding RNA lncCIRBIL disrupts the nuclear translocation of Bclaf1 alleviating cardiac ischemia–reperfusion injury
por: Zhang, Yang, et al.
Publicado: (2021)

Identifying and characterising Thrap3, Bclaf1 and Erh interactions using cross-linking mass spectrometry
por: Shcherbakova, Liudmila, et al.
Publicado: (2023)

Mevalonate improves anti-PD-1/PD-L1 efficacy by stabilizing CD274 mRNA
por: Zhang, Wenxin, et al.
Publicado: (2023)

Role of Bclaf1 in Promoting Adrenocortical Carcinoma Proliferation: A Study Combining the Use of Bioinformatics and Molecular Events
por: Zhou, Hui, et al.
Publicado: (2021)

USP4 promotes the proliferation, migration, and invasion of esophageal squamous cell carcinoma by targeting TAK1
por: Zhang, Hongdian, et al.
Publicado: (2023)

Regulation of PD-1/PD-L1 pathway and resistance to PD-1/PD-L1 blockade
por: Bai, Jie, et al.
Publicado: (2017)

RAG-Mediated DNA Breaks Attenuate PU.1 Activity in Early B Cells through Activation of a SPIC-BCLAF1 Complex
por: Soodgupta, Deepti, et al.
Publicado: (2019)

Ginsenoside Compound K Regulates HIF-1α-Mediated Glycolysis Through Bclaf1 to Inhibit the Proliferation of Human Liver Cancer Cells
por: Zhang, Silin, et al.
Publicado: (2020)

Determining the optimal PD‐1/PD‐L1 inhibitors for the first‐line treatment of non‐small‐cell lung cancer with high‐level PD‐L1 expression in China
por: Teng, Meng‐Meng, et al.
Publicado: (2021)

The anticancer immune response of anti-PD-1/PD-L1 and the genetic determinants of response to anti-PD-1/PD-L1 antibodies in cancer patients
por: Sui, Xinbing, et al.
Publicado: (2015)

PD-L1 Amino Acid Position 88 Represents a Hotspot for PD-L1 Stability With Relevance for PD-L1 Inhibition
por: Claaß, Luise Victoria, et al.
Publicado: (2022)

The RNA processing factors THRAP3 and BCLAF1 promote the DNA damage response through selective mRNA splicing and nuclear export
por: Vohhodina, Jekaterina, et al.
Publicado: (2017)

From rough to precise: PD-L1 evaluation for predicting the efficacy of PD-1/PD-L1 blockades
por: Zhao, Xuan, et al.
Publicado: (2022)

TET2–BCLAF1 transcription repression complex epigenetically regulates the expression of colorectal cancer gene Ascl2 via methylation of its promoter
por: Shang, Yangyang, et al.
Publicado: (2022)

USP5 facilitates non-small cell lung cancer progression through stabilization of PD-L1
por: Pan, Jinghua, et al.
Publicado: (2021)

Biomarkers for predicting efficacy of PD-1/PD-L1 inhibitors
por: Yi, Ming, et al.
Publicado: (2018)

LncRNA PVT1 accelerates malignant phenotypes of bladder cancer cells by modulating miR-194-5p/BCLAF1 axis as a ceRNA
por: Chen, Mingwei, et al.
Publicado: (2020)

HuR up-regulates cell surface PD-L1 via stabilizing CMTM6 transcript in cancer
por: Liu, Yanbin, et al.
Publicado: (2021)

BCLAF1 is a radiation-induced H2AX-interacting partner involved in γH2AX-mediated regulation of apoptosis and DNA repair
por: Lee, Y Y, et al.
Publicado: (2012)

Study on PD-L1 Expression in NSCLC Patients and Related Influencing Factors in the Real World
por: Zhu, Yefei, et al.
Publicado: (2021)

Virtual Screening and In Vitro Evaluation of PD-1 Dimer Stabilizers for Uncoupling PD-1/PD-L1 Interaction from Natural Products
por: Lung, Jrhau, et al.
Publicado: (2020)

PD-1/PD-L1 checkpoint inhibitors in advanced hepatocellular carcinoma immunotherapy
por: Li, Qian, et al.
Publicado: (2022)

Significance of Detection of the HER2 Gene and PD-1/PD-L1 in Gastric Cancer
por: Yun, Tian, et al.
Publicado: (2020)

Correction for: LncRNA PVT1 accelerates malignant phenotypes of bladder cancer cells by modulating miR-194-5p/BCLAF1 axis as a ceRNA
por: Chen, Mingwei, et al.
Publicado: (2021)

PD-L1 Expression and Combined Status of PD-L1/PD-1–Positive Tumor Infiltrating Mononuclear Cell Density Predict Prognosis in Glioblastoma Patients
por: Han, Jiheun, et al.
Publicado: (2017)

PD-L1 regulates genomic stability via interaction with cohesin-SA1 in the nucleus
por: Zhang, Wen, et al.
Publicado: (2021)

Emerging role of ubiquitination/deubiquitination modification of PD-1/PD-L1 in cancer immunotherapy
por: Ding, Peng, et al.
Publicado: (2022)

PD-1/PD-L1 Interaction Maintains Allogeneic Immune Tolerance Induced by Administration of Ultraviolet B-Irradiated Immature Dendritic Cells
por: Zhang, Lanfang, et al.
Publicado: (2016)

Development of PD-1/PD-L1 Pathway in Tumor Immune Microenvironment and Treatment for Non-Small Cell Lung Cancer
por: He, Jiabei, et al.
Publicado: (2015)

Circulating PD-L1 in NSCLC patients and the correlation between the level of PD-L1 expression and the clinical characteristics
por: Zhang, Jie, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_srb6g8920n3fjk6bpgj28dmtog